E
Sell
3/12/2024Downgrade
InnoCan Pharma Corporation (INNPF) was downgraded to E+ from D- on 3/12/2024 due to a significant decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.0021 to -$0.0078, EBIT declined 176.61% from -$436 to -$1.21M, and the quick ratio declined from 4.38 to 1.91.
D
Sell
11/13/2023Upgraded
InnoCan Pharma Corporation (INNPF) was upgraded to D- from E+ on 11/13/2023 due to a large increase in the growth index, volatility index and total return index. Total revenue increased 100.06% from $1.56M to $3.12M, EBIT increased 65.56% from -$1.27M to -$436, and earnings per share increased from -$0.0051 to -$0.0021.
E
Sell
3/14/2023Downgrade
InnoCan Pharma Corporation (INNPF) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
InnoCan Pharma Corporation (INNPF) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
InnoCan Pharma Corporation (INNPF) was downgraded to E+ from D on 2/8/2023 due to a significant decline in the total return index, volatility index and solvency index.
D
Sell
5/5/2022Upgraded
InnoCan Pharma Corporation (INNPF) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
D
Sell
4/20/2022Downgrade
InnoCan Pharma Corporation (INNPF) was downgraded to D- from D on 4/20/2022 due to a noticeable decline in the total return index and volatility index.
D
Sell
12/1/2021Upgraded
InnoCan Pharma Corporation (INNPF) was upgraded to D from D- on 12/1/2021 due to a large increase in the solvency index and total return index. The quick ratio increased from 1.17 to 2.07.
D
Sell
8/2/2021Upgraded
InnoCan Pharma Corporation (INNPF) was upgraded to D- from E+ on 8/2/2021 due to a major increase in the solvency index, total return index and growth index. Total revenue increased 362.5% from $8 to $37, the quick ratio increased from 0.44 to 1.12, and earnings per share increased from -$0.0356 to -$0.0238.
E
Sell
5/3/2021Upgraded
InnoCan Pharma Corporation (INNPF) was upgraded to E+ from E on 5/3/2021 due to a major increase in the total return index and valuation index.
E
Sell
2/24/2021None
InnoCan Pharma Corporation (INNPF) was downgraded to E from U on 02/24/2021.
